Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening

Summary

The purpose of this study is to evaluate how well women may adopt a Contrast-enhanced Spectral Mammography (CESM) as their yearly breast screening test compared to the standard 2-D or 3-D mammogram.

Eligibility

Inclusion Criteria:

* • Female

  * 40 to 69 years
  * Previous normal mammogram (BI-RADS 1 or 2) showing heterogeneous or extremely dense breast tissue within last 24 months
  * Scheduled for screening mammogram as part of the patient's clinical care

Exclusion Criteria:

* • No mammogram within last 24 months

  * Fatty or scattered fibroglandular tissue on last mammogram
  * History of allergy to iodinated contrast
  * History of renal disease or renal function abnormalities
  * Pregnant women
  * History of diabetes
  * History of paraproteinemia syndromes such as multiple myeloma
  * History of collagen vascular disease
  * History of vascular disease (coronary artery disease, myocardial infarction, carotid disease, peripheral vascular disease, or known visceral artery disease)
  * Previously identified as high risk for breast cancer (\>20% lifetime risk)
  * Asthma
  * Sickle Cell Anemia
  * Currently on Dialysis

Conditions4

Locations1 site

Browse More Trials